92 related articles for article (PubMed ID: 1951242)
1. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
[TBL] [Abstract][Full Text] [Related]
2. [Study on the usefulness of haptoglobin used on endoscopic injection sclerotherapy].
Matsumoto A; Miyoshi H; Takada K; Hayashi K; Asada S; Hirata I; Ohshiba S
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1343-9. PubMed ID: 2214258
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.
Hashizume M; Kitano S; Yamaga H; Sugimachi K
Lancet; 1988 Aug; 2(8606):340-1. PubMed ID: 2899760
[No Abstract] [Full Text] [Related]
4. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
[TBL] [Abstract][Full Text] [Related]
5. [The prophylactic effect of haptoglobin administration on renal disfunction in endoscopic injection sclerotherapy].
Miyoshi H; Oshiba S; Matsumoto A; Hayashi K; Tei H
Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):280. PubMed ID: 2754835
[No Abstract] [Full Text] [Related]
6. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate.
Bellary SV; Isaacs P
Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939
[No Abstract] [Full Text] [Related]
7. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy for esophageal varices.
Benjamin SB
DICP; 1990 Nov; 24(11 Suppl):S47-50. PubMed ID: 2270696
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary circulatory disturbance following endoscopic injection sclerotherapy].
Uchibori S
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):833-9. PubMed ID: 8366622
[TBL] [Abstract][Full Text] [Related]
10. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices.
Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K
Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025
[TBL] [Abstract][Full Text] [Related]
11. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices.
Hashizume M; Yamaga H; Kitano S; Sugimachi K
Hepatogastroenterology; 1990 Dec; 37(6):565-8. PubMed ID: 2289769
[TBL] [Abstract][Full Text] [Related]
12. [Deterioration of liver function following endoscopic injection sclerotherapy of esophageal varices--significance of a new index for liver function "delta TB"].
Matsumoto H; Suzuki F; Souda K; Kitahara H; Kobayashi Y; Tsugiki M; Kawasaki T; Nakao K; Matsumoto M; Iwata K
Nihon Shokakibyo Gakkai Zasshi; 1994 Nov; 91(11):2049-55. PubMed ID: 7815720
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
[TBL] [Abstract][Full Text] [Related]
14. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports.
Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K
Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446
[TBL] [Abstract][Full Text] [Related]
15. [Disturbances of pulmonary gas exchange after sclerotherapy for esophageal varices].
Rusiniak K; Szczepanik AB; Ratajczak J; Meissner AJ
Wiad Lek; 1997; 50 Suppl 1 Pt 1():298-302. PubMed ID: 9446371
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial.
Shigemitsu T; Yoshida T; Harada T; Takeo Y; Nakamura H; Okita K
Hepatogastroenterology; 2000; 47(33):733-7. PubMed ID: 10919021
[TBL] [Abstract][Full Text] [Related]
17. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
[TBL] [Abstract][Full Text] [Related]
18. Sequential esophageal motility studies after endoscopic injection sclerotherapy: a prospective investigation.
Grande L; Planas R; Lacima G; Boix J; Ros E; Esteve M; Morillas R; Gasull MA
Am J Gastroenterol; 1991 Jan; 86(1):36-40. PubMed ID: 1986552
[TBL] [Abstract][Full Text] [Related]
19. Adenosquamous carcinoma of the esophagus after endoscopic variceal sclerotherapy: a case report and review of the literature.
Sakata K; Ishida M; Hiraishi H; Sasai T; Watanabe N; Suzuki Y; Masuyama H; Terano A
Gastrointest Endosc; 1998 Mar; 47(3):294-9. PubMed ID: 9540886
[No Abstract] [Full Text] [Related]
20. [Renal tubular dysfunction in open pediatric heart surgery--preventive effect of haptoglobin].
Kawai T; Wada Y; Kitaura K; Nakajima S; Enmoto T; Oka T
Nihon Kyobu Geka Gakkai Zasshi; 1994 Aug; 42(8):1137-41. PubMed ID: 7963826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
